We have located links that may give you full text access.
Estimation of serum ferritin level in potentially malignant disorders, oral squamous cell carcinoma, and treated cases of oral squamous cell carcinoma.
INTRODUCTION: Serum ferritin is the best indicator of iron stores in the body. The level of serum ferritin was found to be elevated in number of malignancies. Serum ferritin is also been established as prognostic marker for malignant lymphoma, cervical cancer, breast cancer, etc.
AIMS AND OBJECTIVE: The aim of this study is to evaluate the level of serum ferritin in patients with pretreatment and posttreatment of squamous cell carcinoma and to determine the significance of serum ferritin as prognostic marker for oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: Blood samples of 15 normal, thirty potentially malignant lesions, and thirty patients of squamous cell carcinoma were taken and analyzed for serum ferritin using ELISA. Of thirty patients, 15 patients were followed up till 6 months after their treatment and serum ferritin was again determined.
RESULTS: The average serum ferritin of 30 potentially malignant disorders was 62.70 ng/ml, and thirty patients with squamous cell carcinoma were found to be 162.47 ng/dl. After 6 months of the treatment, the mean fall in serum ferritin with nonrecurrence patients was 84 ng/dl and increase in the serum ferritin in recurrence cases was 13.4 ng/dl.
CONCLUSION: Determining serum ferritin is a convenient and nonexpensive method to determine the outcome of the treatment of the cases with OSCC. Its potential as prognostic marker could not be overlooked.
AIMS AND OBJECTIVE: The aim of this study is to evaluate the level of serum ferritin in patients with pretreatment and posttreatment of squamous cell carcinoma and to determine the significance of serum ferritin as prognostic marker for oral squamous cell carcinoma (OSCC).
MATERIALS AND METHODS: Blood samples of 15 normal, thirty potentially malignant lesions, and thirty patients of squamous cell carcinoma were taken and analyzed for serum ferritin using ELISA. Of thirty patients, 15 patients were followed up till 6 months after their treatment and serum ferritin was again determined.
RESULTS: The average serum ferritin of 30 potentially malignant disorders was 62.70 ng/ml, and thirty patients with squamous cell carcinoma were found to be 162.47 ng/dl. After 6 months of the treatment, the mean fall in serum ferritin with nonrecurrence patients was 84 ng/dl and increase in the serum ferritin in recurrence cases was 13.4 ng/dl.
CONCLUSION: Determining serum ferritin is a convenient and nonexpensive method to determine the outcome of the treatment of the cases with OSCC. Its potential as prognostic marker could not be overlooked.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app